Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVTA
2501
DELISTED
Avantax, Inc. Common Stock
AVTA
| $5.72M | ﹤0.01% |
255,683
+216,591
| +554% | +$5.1M |
|
2502
C.H. Robinson
CHRW
$17.7B
| $5.72M | ﹤0.01% |
60,633
+7,441
| +14% | +$719K |
|
2503
CALL
CSX Corp
CSX
$95.5B
| $5.72M | ﹤0.01% |
167,700
-289,200
| -63% | -$9.15M |
|
|
CERE
2504
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $5.72M | ﹤0.01% |
179,795
-285,195
| -61% | -$8.75M |
|
|
WW
2505
PUT
DELISTED
WW International
WW
| $5.71M | ﹤0.01% |
+850,000
| New | +$6.03M |
|
2506
PUT
NetEase
NTES
$78.6B
| $5.7M | ﹤0.01% |
+59,000
| New | +$5.33M |
|
2507
XBiotech
XBIT
$70.1M
| $5.7M | ﹤0.01% |
959,758
+914,107
| +2,002% | +$4.12M |
|
2508
Lakeland Financial Corp
LKFN
$1.47B
| $5.7M | ﹤0.01% |
117,413
-28,452
| -20% | -$1.49M |
|
2509
PUT
Glaukos
GKOS
$10.7B
| $5.7M | ﹤0.01% |
80,000
+40,000
| +100% | +$2.3M |
|
2510
CALL
Skyworks Solutions
SWKS
$10.1B
| $5.69M | ﹤0.01% |
51,400
+22,400
| +77% | +$2.36M |
|
2511
Accel Entertainment
ACEL
$950M
| $5.68M | ﹤0.01% |
537,427
+323,865
| +152% | +$3.04M |
|
2512
Trupanion
TRUP
$1.3B
| $5.68M | ﹤0.01% |
288,375
+264,895
| +1,128% | +$7.47M |
|
2513
California Resources
CRC
$4.7B
| $5.67M | ﹤0.01% |
125,241
-938,298
| -88% | -$38.1M |
|
2514
Vital Farms
VITL
$448M
| $5.67M | ﹤0.01% |
472,859
+248,393
| +111% | +$3.47M |
|
2515
CALL
T. Rowe Price
TROW
$24B
| $5.67M | ﹤0.01% |
50,600
-6,500
| -11% | -$712K |
|
|
DOCU
2516
PUT
DocuSign
DOCU
$12.2B
| $5.65M | ﹤0.01% |
110,600
+51,200
| +86% | +$2.71M |
|
2517
CALL
Southern Company
SO
$102B
| $5.64M | ﹤0.01% |
80,300
-350,600
| -81% | -$25.1M |
|
2518
Sociedad Química y Minera de Chile
SQM
$23B
| $5.64M | ﹤0.01% |
77,668
-379,545
| -83% | -$27M |
|
2519
PUT
ResMed
RMD
$34B
| $5.64M | ﹤0.01% |
+25,800
| New | +$5.75M |
|
2520
CALL
Twilio
TWLO
$37.1B
| $5.62M | ﹤0.01% |
88,400
-129,500
| -59% | -$7.64M |
|
2521
UBS Group
UBS
$166B
| $5.6M | ﹤0.01% |
276,285
+60,933
| +28% | +$1.23M |
|
|
SLVR
2522
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
| $5.6M | ﹤0.01% |
539,069
| – | – |
|
2523
AMC Global Media
AMCX
$509M
| $5.59M | ﹤0.01% |
467,940
+244,120
| +109% | +$3.52M |
|
2524
Charter Communications
CHTR
$17.7B
| $5.59M | ﹤0.01% |
15,209
-161,594
| -91% | -$55.1M |
|
2525
CALL
Otis Worldwide
OTIS
$27.2B
| $5.58M | ﹤0.01% |
62,700
-1,100
| -2% | -$92.7K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.